(ALNY) Alnylam Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Alnylam Pharmaceuticals | (ALNY) share price targets
Complete technical analysis of Alnylam Pharmaceuticals (ALNY) by charts plus indicators, forecast predictions and share price targets for Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-13 View latest technical analysis
10 day averaged volume of Alnylam Pharmaceuticals is 640660
| Date | Daily Closing Price | Open | High | Low | Volume |
| 13 Thu Feb 2025 | 264.89 | 258.60 | 268.52 | 256.65 | 1.2 times |
| 12 Wed Feb 2025 | 265.96 | 265.93 | 268.20 | 261.69 | 1.281 times |
| 11 Tue Feb 2025 | 268.99 | 272.19 | 273.23 | 266.98 | 0.442 times |
| 10 Mon Feb 2025 | 274.06 | 275.41 | 276.23 | 267.92 | 1.286 times |
| 07 Fri Feb 2025 | 276.19 | 276.91 | 278.03 | 272.35 | 0.732 times |
| 06 Thu Feb 2025 | 278.25 | 276.09 | 279.24 | 274.05 | 0.825 times |
| 05 Wed Feb 2025 | 276.31 | 272.15 | 278.44 | 272.15 | 1.171 times |
| 04 Tue Feb 2025 | 271.00 | 273.15 | 277.98 | 269.05 | 1.16 times |
| 03 Mon Feb 2025 | 274.55 | 270.78 | 278.51 | 266.21 | 1.216 times |
| 31 Fri Jan 2025 | 271.31 | 276.86 | 279.34 | 270.26 | 1.012 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 261.1 as stoploss in an intra day buy trade for a target of 270.35. However, stock will show a bearish move below 261.1.
Share price targets for Alnylam Pharmaceuticals (ALNY)
| Target Type | Value |
| Downside Target | 229.86 |
| Downside Target | 245.69 |
| Downside Target | 251.23 |
| Downside Target | 263.65 |
| Upside Target | 276.23 |
| Upside Target | 279.24 |
| Upside Target | 279.67 |
| Upside Target | 286.58 |
| Upside Target | 287.22 |
| Upside Target | 304.39 |
Intraday share price targets for Alnylam Pharmaceuticals (ALNY)
| Target Type | Value |
| Downside Intraday Target | 255.62 |
| Downside Intraday Target | 246.34 |
| Upside Intraday Target | 275.2 |
| Upside Intraday Target | 285.5 |
| Upside Intraday Target | 265.92 |
Weekly technical analysis of Alnylam Pharmaceuticals (ALNY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 13 Thu Feb 2025 | 264.89 | 275.41 | 276.23 | 256.65 | 0.825 times |
| 07 Fri Feb 2025 | 276.19 | 270.78 | 279.24 | 266.21 | 1.094 times |
| 31 Fri Jan 2025 | 271.31 | 277.01 | 287.22 | 269.00 | 0.907 times |
| 24 Fri Jan 2025 | 278.76 | 251.37 | 279.67 | 251.23 | 5.905 times |
| 17 Fri Jan 2025 | 246.27 | 251.28 | 253.50 | 245.69 | 0.135 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Alnylam Pharmaceuticals (ALNY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 13 Thu Feb 2025 | 264.89 | 270.78 | 279.24 | 256.65 | 0.399 times |
| 31 Fri Jan 2025 | 271.31 | 237.92 | 287.22 | 231.00 | 1.75 times |
| 31 Tue Dec 2024 | 235.31 | 255.39 | 258.00 | 233.00 | 0.466 times |
| 26 Tue Nov 2024 | 253.35 | 267.05 | 286.58 | 229.86 | 0.997 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Alnylam Pharmaceuticals (ALNY)
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Alnylam Pharmaceuticals in short term but the sell signal is initial and weak.
Alnylam Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 271.96 and Alnylam Pharmaceuticals (ALNY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals (ALNY) stock. Volume based technical analysis of Alnylam Pharmaceuticals (ALNY) stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Alnylam Pharmaceuticals in short term but the sell signal is initial and weak.
Alnylam Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 271.96 and Alnylam Pharmaceuticals (ALNY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals (ALNY) stock. Volume based technical analysis of Alnylam Pharmaceuticals (ALNY) stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.